about
Aging eye microbiota in Dry Eye Syndrome in patients treated with Enterococcus faecium and Saccharomyces boulardii.Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance.Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer.Resveratrol in Patients with Minimal Hepatic Encephalopathy.Microbiological Etiology of Chronic Skin Lesions in Type 2 Diabetic SubjectsD-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosisBiomarkers in colorectal cancer: Current clinical utility and future perspectivesOlive Oil Effects on Colorectal CancerHypothyroidism as a Predictor of Surgical Outcomes in the ElderlyEndothelial Function in Obese Patients Treated with Bariatric SurgeryGlobal, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease StudyCilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery diseaseDiagnosis and treatment of hypothyroidism in old people : A new old challengeHomocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein ThrombosisEffects of vildagliptin, a DPP-4 inhibitor, in elderly diabetic patients with mild cognitive impairmentSurgical approach and geriatric evaluation for elderly patients with colorectal cancerMetabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics and Diabetes Control Study)Etiology of chronic skin lesions in subjects with peripheral arterial disease
P50
Q38694255-5843CF9D-63F8-4BC3-B45A-4193DF7190BEQ40078355-9A78DF27-A5F9-4CA5-B5CC-1FCB6CB89564Q52688594-53A47820-2F4B-4EE5-9FAB-CD705B647A46Q53438002-847B8588-BA1D-4ADC-A0DC-2861C8A44CE7Q54238006-FB5CFE1B-CF74-4E38-9AE7-8070E1B63CDEQ57484445-0396D3E1-6238-47AD-9853-1CA421877E98Q60046390-A9AFE267-D484-4186-A07A-26451651F027Q61813893-66EC746B-BDF0-436A-9FE7-22F305B2AA49Q64092928-1E88AE6F-2EF1-418F-AB27-989560633FD3Q89883913-A28A8F13-A3DE-4CE7-A588-30DF928671ECQ90327567-ADE284F3-3861-4727-AE80-3617CD877243Q90706999-88E0C684-453D-4F42-B288-45A4B248F8E1Q91479927-CFFEBA38-FD92-4642-8DBC-7F2FD414B27EQ92676682-9F69ADB9-C3CA-45EE-9D6A-4B78C96DCA6EQ92781205-C22C9859-0DF1-4D2F-9074-CB11A2C1173CQ92888735-4667DCFD-28F1-4EE8-8DBC-212458B48A9EQ92905878-5558D869-7299-419C-840D-F55957320DB9Q95801542-1C34711B-FED1-4882-9782-B157AA5D34F1
P50
description
researcher ORCID ID = 0000-0001-6984-308X
@en
wetenschapper
@nl
name
Antonio Maria Borzì
@ast
Antonio Maria Borzì
@en
Antonio Maria Borzì
@es
Antonio Maria Borzì
@nl
type
label
Antonio Maria Borzì
@ast
Antonio Maria Borzì
@en
Antonio Maria Borzì
@es
Antonio Maria Borzì
@nl
prefLabel
Antonio Maria Borzì
@ast
Antonio Maria Borzì
@en
Antonio Maria Borzì
@es
Antonio Maria Borzì
@nl
P1153
P1153
57000246800
57194721685
57195426657
57200199389
P21
P31
P496
0000-0001-6984-308X